Platinum-Based Twin Drug Modulates Tumor-Infiltrating Immune Cells to Improve Immune Checkpoint Blockade Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Platinum-Based Twin Drug Modulates Tumor-Infiltrating Immune Cells to Improve Immune Checkpoint Blockade Therapy

Published:2023-09-20 Issue:19 Volume:66 Page:13607-13621
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Hao Yuhao¹,Li Rui¹,Min Yuanzeng¹²³^ORCID

Affiliation:

1. Department of Chemistry, University of Science and Technology of China, Hefei 230026, China

2. Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, Anhui Provincial Hospital, University of Science and Technology of China, Hefei 230026, China

3. CAS Key Lab of Soft Matter Chemistry, University of Science and Technology of China, Hefei 230026, China

Funder

Fundamental Research Funds for the Central Universities

National Natural Science Foundation of China

Start-Up grant from University of Science and Technology of China

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.3c00946

Reference60 articles.

1. Challenges and opportunities in the PD1/PDL1 inhibitor clinical trial landscape

2. Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial

3. Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors

4. Combination strategies to maximize the benefits of cancer immunotherapy

5. Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP